Jonathan W. Dickerson

Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents

Jerri M. Rook, Zixiu Xiang, Xiaohui Lv et al. · Neuron · 2015 · 128 citations · Full text

Signal Transduction, Molecular Physiology, Mglu 5 +9

Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model

Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson et al. · Neuropsychopharmacology · 2015 · 102 citations · Full text

Synaptic Plasticity, Neuropsychology, Cognitive Symptoms +13

The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease

Carrie K. Jones, Michael Bubser, Analisa D. Thompson et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 99 citations

Stress exacerbates experimental Parkinson’s disease

Ann M. Hemmerle, Jonathan W. Dickerson, James P. Herman et al. · Molecular Psychiatry · 2013 · 81 citations

Neurodegenerative Diseases, Stress, Parkinson Disease +8

M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition

Sean P. Moran, Jonathan W. Dickerson, Hyekyung P. Cho et al. · Neuropsychopharmacology · 2018 · 79 citations · Full text

M1-positive Allosteric Modulators, Cognitive Science, Optimal Profile +9